Serhii Holota

960 total citations
59 papers, 669 citations indexed

About

Serhii Holota is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Serhii Holota has authored 59 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Organic Chemistry, 13 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Serhii Holota's work include Synthesis and biological activity (38 papers), Synthesis and Characterization of Heterocyclic Compounds (21 papers) and Synthesis of heterocyclic compounds (11 papers). Serhii Holota is often cited by papers focused on Synthesis and biological activity (38 papers), Synthesis and Characterization of Heterocyclic Compounds (21 papers) and Synthesis of heterocyclic compounds (11 papers). Serhii Holota collaborates with scholars based in Ukraine, Poland and France. Serhii Holota's co-authors include Roman Lesyk, Andrzej Gzella, Lucjusz Zaprutko, Krzysztof Bielawski, Andriy Cherkas, Anna Bielawska, Piotr Roszczenko, Olga Klaudia Szewczyk-Roszczenko, Rosita Gabbianelli and Neven Žarković and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Serhii Holota

54 papers receiving 644 citations

Peers

Countries citing papers authored by Serhii Holota

Since Specialization

Citations

This map shows the geographic impact of Serhii Holota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhii Holota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhii Holota more than expected).

Fields of papers citing papers by Serhii Holota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serhii Holota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhii Holota. The network helps show where Serhii Holota may publish in the future.

Co-authorship network of co-authors of Serhii Holota

This figure shows the co-authorship network connecting the top 25 collaborators of Serhii Holota. A scholar is included among the top collaborators of Serhii Holota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serhii Holota. Serhii Holota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells 2025 ·Cells ·(unknown), (unknown), (unknown), Robert Czarnomysy, Agnieszka Gornowicz, Olexandr Karpenko, Serhii Holota, Anna Bielawska, Krzysztof Bielawski, Roman Lesyk	0
2	THE ROLE OF SOCIAL MEDIA IN SHAPING SCIENTIFIC MEDICAL JOURNALS 2025 ·(unknown), Serhii Holota, Anna Kryshchyshyn‐Dylevych, (unknown), (unknown), Оksana Zayachkivska, Walter P. Maksymowych, (unknown)	0
3	Evaluation of thiopyrano[2,3‐d]thiazole derivatives as potential anticonvulsant agents 2024 ·Archiv der Pharmazie ·(unknown), (unknown), (unknown), (unknown), (unknown), Olga Klyuchivska, Olexandr Karpenko, Roman Lesyk, Serhii Holota	1
4	A New 4-Thiazolidinone Derivative (Les-6490) as a Gut Microbiota Modulator: Antimicrobial and Prebiotic Perspectives 2024 ·Antibiotics ·(unknown), (unknown), (unknown), Serhii Holota, (unknown), (unknown), Alicja Sękowska, Yuriy Salyha, (unknown), Roman Lesyk	0
5	Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines 2024 ·Cells ·(unknown), Bartosz Skóra, Serhii Holota, (unknown), (unknown), Roman Lesyk, Konrad A. Szychowski	2
6	The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications 2023 ·Cells ·Olga Klaudia Szewczyk-Roszczenko, Piotr Roszczenko, Anna Shmakova, Nataliya Finiuk, Serhii Holota, Roman Lesyk, Anna Bielawska, Yegor Vassetzky, Krzysztof Bielawski	29
7	Development of standardization methods of gel with sapropel extract and their validation 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Serhii Holota, (unknown)	1
8	Fused Triazole-Azepine Hybrids as Potential Non-Steroidal Antiinflammatory Agents 2023 ·Scientia Pharmaceutica ·(unknown), Roman Lesyk, (unknown), Serhii Holota, (unknown), (unknown), (unknown)	13
9	Convenient Synthesis of 4-pyridinyloxy-Modified imidazo[2,1-b][1,3]thiazines as Potential Anti-inflammatory Agents 2022 ·Biointerface Research in Applied Chemistry ·(unknown), (unknown), Serhii Holota, (unknown), (unknown), (unknown), М. В. Вовк, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
10	AN EXPLORATORY STUDY OF PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS TO IDENTIFY SIMPLE, ROBUST AND RELEVANT BIOMARKERS FOR THERAPEUTIC INTERVENTIONS FOR PTSD: STUDY RATIONALE, KEY ELEMENTS OF DESIGN AND A CONTEXT OF WAR IN UKRAINE 2022 ·Victoria Serhiyenko, Klaus Holzmann, Serhii Holota, (unknown), Armen Nersesyan, (unknown), (unknown), (unknown), Miroslav Mišík, (unknown), Olha Strilbytska, (unknown), Oleh Lushchak, Siegfried Knasmüller, Andriy Cherkas	8
11	4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design 2022 ·International Journal of Molecular Sciences ·Piotr Roszczenko, Serhii Holota, Olga Klaudia Szewczyk-Roszczenko, (unknown), Krzysztof Bielawski, Anna Bielawska, Roman Lesyk	49
12	Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents 2022 ·Molecules ·(unknown), (unknown), Piotr Roszczenko, (unknown), Nataliya Finiuk, (unknown), Serhii Holota, Robert Czarnomysy, Olga Klyuchivska, (unknown), (unknown), Andrzej Gzella, Krzysztof Bielawski, Anna Bielawska, Rostyslav Stoika, Roman Lesyk	19
13	Synthesis and Evaluation of Bioactivity of 6-[(2-Pyridinyloxy)](Benzo)Imidazo[2,1-b][1,3]Thiazine Derivatives 2021 ·Biointerface Research in Applied Chemistry ·(unknown), (unknown), Serhii Holota, (unknown), (unknown), (unknown), М. В. Вовк, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	5
14	Synthesis and Evaluation of Antimicrobial and Anti-inflammatory Activity of 6-aryliden-2-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazoles 2021 ·Biointerface Research in Applied Chemistry ·(unknown), Serhii Holota, (unknown), (unknown), (unknown), (unknown), М. В. Вовк, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
15	Synthesis, Characterization and In Vitro Evaluation of Novel 5-Ene-thiazolo[3,2-b][1,2,4]triazole-6(5H)-ones as Possible Anticancer Agents 2021 ·Molecules ·Serhii Holota, (unknown), (unknown), Andrzej Gzella, Andriy Cherkas, Roman Lesyk	22
16	N-(3-Cyano-4,5,6,7-tetrahydrobenzothiophen-2-yl)-2-[[5-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide 2021 ·SHILAP Revista de lepidopterología ·Serhii Holota, (unknown), (unknown), (unknown), Roman Lesyk	5
17	Synthesis, the antiexudative and antimicrobial activity of 6-arylidene substituted imidazo[2,1-b]thiazoles 2021 ·SHILAP Revista de lepidopterología ·(unknown), Serhii Holota, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
18	5-[4-(tert-Butyl)cyclohexylidene]-2-thioxothiazolidin-4-one 2021 ·SHILAP Revista de lepidopterología ·Serhii Holota, Andrii Lozynskyi, (unknown), (unknown), Roman Lesyk	1
19	Synthesis and Biological Activity Evaluation of Polyfunctionalized Anthraquinonehydrazones 2020 ·Letters in Drug Design & Discovery ·Andrii Lozynskyi, Serhii Holota, (unknown), (unknown), Olexandr Karpenko, Volodymyr Novikov, Roman Lesyk	6
20	ВИВЧЕННЯ ГОСТРОЇ ТОКСИЧНОСТІ ТА ПРОТИЗАПАЛЬНОЇ АКТИВНОСТІ СПИРТОВИХ ЕКСТРАКТІВ ТРАВИ СНУ БІЛОГО (PULSATILA ALBA) 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Serhii Holota, (unknown), (unknown), (unknown), Volodymyr Novikov	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact